Cheyenne Rincones , APRN
Nurse Practitioner - Primary Care • El Paso, TX
3427 Pershing Dr.
El Paso, TX 799032754
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Cheyenne Rincones is listed in NPPES under Nurse Practitioner - Primary Care.
-
NPI assigned on October 16, 2013; this date does not establish years in practice.
-
Published CMS data list 150 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 133 service units.
- 99204 — New patient outpatient office visit: 17 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,464 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 136 prescription fills, including refills.
- Levothyroxine Sodium — 82 prescription fills, including refills.
- Amlodipine Besylate — 78 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 50 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 60% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 198 clinicians with data). Median for this group: 305. Middle half: 83 to 706.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 103 in 2019 to 150 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2024.
Practice Location & Contact Primary Location
3427 Pershing Dr.
El Paso, TX 799032754
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner - Primary Care: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
59 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $16,177 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $9,796 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,280 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$190,828 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $765.68 across 13 records.
By nature of payment
- Food and Beverage: $765.68 across 13 records.
Reporting-company totals (3 largest of 7)
- ABBVIE INC.: $455.01 across 6 records.
- Novo Nordisk Inc: $124.99 across 1 record.
- REVANCE THERAPEUTICS, INC.: $96.99 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Cheyenne Rincones has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Cheyenne Rincones as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 60% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 198 clinicians with data). Median for this group: 305. Middle half: 83 to 706.
Too few clinicians listed under Nurse Practitioner - Primary Care in El Paso have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 198 clinicians with data). Median for this group: $21,259. Middle half: $7,086 to $49,977.
Too few clinicians listed under Nurse Practitioner - Primary Care in El Paso have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 60% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 198 clinicians with data). Median for this group: $15,621. Middle half: $5,094 to $36,763.
Too few clinicians listed under Nurse Practitioner - Primary Care in El Paso have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 299 clinicians with data). Median for this group: 552. Middle half: 142 to 1,484.
Too few clinicians listed under Nurse Practitioner - Primary Care in El Paso have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 299 clinicians with data). Median for this group: $40,304. Middle half: $2,549 to $139,469.
Too few clinicians listed under Nurse Practitioner - Primary Care in El Paso have Medicare Part D data for 2024 to compare.
21 active clinicians are listed under Nurse Practitioner - Primary Care with a practice address in El Paso, TX (844 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
4.8% of these 21 clinicians have the CMS telehealth indicator.
28.6% of these 21 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 46% from 103 in 2019 to 150 in 2024.
- 2019: 103
- 2020: 47
- 2021: 153
- 2023: 100
- 2024: 150
-
Medicare-allowed amount
Medicare-allowed amount increased 123% from $7,254 in 2019 to $16,177 in 2024.
- 2019: $7,254
- 2020: $3,418
- 2021: $3,548
- 2023: $10,466
- 2024: $16,177
-
Paid by Medicare
Paid by Medicare increased 109% from $4,677 in 2019 to $9,796 in 2024.
- 2019: $4,677
- 2020: $1,953
- 2021: $3,169
- 2023: $7,126
- 2024: $9,796
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 1,557 in 2020 and 1,464 in 2024.
- 2020: 1,557
- 2021: 1,179
- 2022: 90
- 2023: 1,013
- 2024: 1,464
-
30-day fills
30-day fills decreased 15% from 3,870 in 2020 to 3,280 in 2024.
- 2020: 3,870
- 2021: 3,032
- 2022: 263
- 2023: 2,227
- 2024: 3,280
-
Part D drug cost
Part D drug cost increased 29% from $148,411 in 2020 to $190,828 in 2024.
- 2020: $148,411
- 2021: $110,589
- 2022: $769
- 2023: $169,046
- 2024: $190,828
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $668.20 in 2021 to $765.68 in 2025.
- 2021: $668.20
- 2022: $796.18
- 2023: $400.54
- 2024: $332.86
- 2025: $765.68
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 13 records totaling $765.68.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $128.80 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $124.99 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $108.32 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $107.49 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $96.99 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $84.33 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $20.09 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $18.33 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $17.86 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $16.29 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $16.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VIBERZI | General | $13.20 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $12.87 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
133 | 50 | $190.00 | $104.22 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
17 | 17 | $245.00 | $136.20 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 136 | 12,310 | $595.08 | 53 |
| Levothyroxine Sodium | Levothyroxine Sodium | 82 | 6,710 | $1,242.34 | 26 |
| Amlodipine Besylate | Amlodipine Besylate | 78 | 6,092 | $295.98 | 26 |
| Mounjaro | Tirzepatide | 59 | 1,792 | $68,885.88 | 12 |
| Losartan Potassium | Losartan Potassium | 56 | 4,830 | $290.10 | 22 |
| Tramadol Hcl | Tramadol Hcl | 53 | 1,292 | $420.69 | 13 |
| Metformin Hcl | Metformin Hcl | 51 | 4,495 | $159.00 | 18 |
| Lisinopril | Lisinopril | 46 | 4,210 | $262.78 | 16 |
| Famotidine | Famotidine | 41 | 3,495 | $905.81 | 19 |
| Naproxen | Naproxen | 38 | 1,057 | $229.28 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 37 | 2,040 | $450.07 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 35 | 2,550 | $372.42 | 12 |
| Ozempic | Semaglutide | 35 | 1,540 | $50,785.17 | — |
| Montelukast Sodium | Montelukast Sodium | 34 | 2,950 | $177.03 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 33 | 720 | $1,119.36 | 14 |
| Ibuprofen | Ibuprofen | 32 | 990 | $284.34 | — |
| Omeprazole | Omeprazole | 31 | 2,488 | $578.81 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | 2,450 | $95.58 | 13 |
| Pregabalin | Pregabalin | 27 | 1,785 | $563.00 | 14 |
| Trazodone Hcl | Trazodone Hcl | 26 | 2,185 | $73.20 | — |
| Hydrochlorothiazide | Hydrochlorothiazide | 25 | 2,300 | $66.36 | — |
| Metoprolol Succinate | Metoprolol Succinate | 24 | 2,190 | $380.24 | — |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | 684 | $159.47 | — |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | 1,880 | $155.21 | — |
| Carvedilol | Carvedilol | 21 | 1,720 | $76.68 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-08-11NUCC Taxonomy Code: 363LP2300X
NUCC Taxonomy Code: 363LP2300X
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20140402002084
TX
4486885530
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3427 PERSHING DR., EL PASO, TX 799032754 (Tel: 9152011190)
Registered at 3427 PERSHING DR., EL PASO, TX 799032754 (Tel: 9152011190)
Recorded as CHEYENNE RINCONES, APRN
NPI status registered as active in NPPES database
Registered at 9849 KENWORTHY ST, EL PASO, TX 799244402 (Tel: 9157454404)
Registered at 14021 HIGHWEED DR, EL PASO, TX 799285581 (Tel: 9152418387)
Recorded as CHEYENNE RINCONES
Nurse Practitioner (license number reported to NPPES: TX 708874)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioner - Primary Care Specialists in El Paso
- Francisca Sequeira Serna
- Sandra Herrera, FNP
- Mindy Solano, FNP-C
- Luis Garcia, MSN, APRN, AGNP-C
- Norma Jacquez, RN, APRN, FNP-C
- Laura Lightner, NURSE PRACTITIONER
Mailing Address
3427 Pershing Dr.
El Paso, TX 799032754
Phone: 9152011190